Black Diamond Therapeutics, Inc. — SCHEDULE 13G/A Filings
4 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Black Diamond Therapeutics, Inc. (BDTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Black Diamond Therapeutics, Inc. has filed 4 SCHEDULE 13G/A documents with the SEC since 2017. To view all SEC filings by Black Diamond Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000902664-26-001085 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0002052113-25-001839 | Apr 29, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-026516 | Mar 21, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-013934 | Feb 14, 2025 | — |